Philip Pizzo, MD | UniHealth

Medicare standing: 2 flags on the record; Listed below.
Plans that list them: Not verified; Not the same as out of network.
Office: 1

On the public record

Medicare does not list them as allowed to order and refer
California licence: Delinquent

Offices

1 location

Plan participation

Not verified

We could not verify current plan participation for this doctor. This does not mean they are out of network. Call Dr. Pizzo’s office at (650) 497-8000 to ask if they take your plan before you enroll.

California Medical Board record

Licence G86370 · Delinquent

Licence status: Delinquent · since 2002 · expires 2021-12-31 · University of Rochester School of Medicine.

License renewal fee has not been paid. No practice is permitted.

No disciplinary actions, convictions, malpractice judgments or citations in this record.

Money from drug and device companies

$2,521,648 in 2022

Sort by

Industry payments by year

2022	2	14	$51,034	$2,521,648
2021	1	4	$57,500	$57,500
2020	1	2	$28,750	$28,750

Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.

A payment is not proof that care is biased.

Sort by

Payments by company

Pfizer	None	$2,470,614	8 payments Acquisitions · 2022-10-05 · $91,500 Acquisitions · 2022-10-05 · $246,600 Acquisitions · 2022-10-05 · $660,300 Acquisitions · 2022-10-05 · $258,720 Acquisitions · 2022-10-05 · $393,750 Acquisitions · 2022-10-05 · $175,896 Acquisitions · 2022-10-05 · $624,172 Acquisitions · 2022-10-05 · $19,676
Global Blood Therapeutics	Oxbryta	$51,034	6 payments Consulting for Oxbryta · 2022-10-04 · $917 Consulting for Oxbryta · 2022-09-28 · $331 Consulting for Oxbryta · 2022-07-19 · $16,875 Consulting for Oxbryta · 2022-04-12 · $18,236 Consulting for Oxbryta · 2022-04-05 · $300 Consulting for Oxbryta · 2022-01-18 · $14,375

See all 14 published payments

Sort by

Every published payment

Pfizer	Acquisitions · 2022-10-05	None	$91,500
Pfizer	Acquisitions · 2022-10-05	None	$246,600
Pfizer	Acquisitions · 2022-10-05	None	$660,300
Pfizer	Acquisitions · 2022-10-05	None	$258,720
Pfizer	Acquisitions · 2022-10-05	None	$393,750
Pfizer	Acquisitions · 2022-10-05	None	$175,896
Pfizer	Acquisitions · 2022-10-05	None	$624,172
Pfizer	Acquisitions · 2022-10-05	None	$19,676
Global Blood Therapeutics	Consulting · 2022-10-04	Oxbryta	$917
Global Blood Therapeutics	Consulting · 2022-09-28	Oxbryta	$331
Global Blood Therapeutics	Consulting · 2022-07-19	Oxbryta	$16,875
Global Blood Therapeutics	Consulting · 2022-04-12	Oxbryta	$18,236
Global Blood Therapeutics	Consulting · 2022-04-05	Oxbryta	$300
Global Blood Therapeutics	Consulting · 2022-01-18	Oxbryta	$14,375

See earlier years (2021, 2020)

2021: $57,500

Sort by

Payments by company in 2021

Global Blood Therapeutics	Oxbryta	$57,500	4 payments Consulting for Oxbryta · 2021-10-27 · $14,375 Consulting for Oxbryta · 2021-07-15 · $14,375 Consulting for Oxbryta · 2021-05-13 · $14,375 Consulting for Oxbryta · 2021-03-23 · $14,375

2020: $28,750

Sort by

Payments by company in 2020

Global Blood Therapeutics	Oxbryta	$28,750	2 payments Consulting for Oxbryta · 2020-12-02 · $14,375 Consulting · 2020-08-12 · $14,375

Professional record

NPI: 1487789756
Licence: CA G86370California G86370: Delinquent · expires 2021-12-31

More record details

Sole proprietor: No
Medicaid ID: CA 00G863700
Taxonomy: Federal specialty code 2080P0207X (2080P0207X)
Mailing address: 2680 Hanover St, Palo Alto, CA, 94304
NPI first listed: 2007-02-23
NPI last updated: 2008-03-20

This is when the NPI record was last certified, not a medical board exam.